Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Bristol-Myers Squibb

    NYSE: BMY · Real-Time Price · USD
    48.47
    0.66 (1.38%)
    At close: Aug 15, 2025, 3:59 PM
    48.50
    0.07%
    After-hours: Aug 15, 2025, 07:58 PM EDT

    Bristol-Myers Squibb Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Revenue
    		 47.7B 47.64B 48.3B 47.44B 46.51B 45.53B 45.01B 44.94B 45.19B 45.85B 46.16B 46.74B 47.14B 46.96B 46.38B 45.47B 44.38B 42.81B
    Cost of Revenue
    		 18.25B 19.45B 20.87B 20.93B 20.41B 20.1B 19.65B 19.58B 19.61B 19.6B 19.67B 19.55B 19.63B 19.53B 19.62B 19.66B 19.78B 19.87B
    Gross Profit
    		 29.45B 28.18B 27.43B 26.5B 26.1B 25.43B 25.36B 25.36B 25.58B 26.25B 26.49B 27.19B 27.52B 27.43B 26.76B 25.81B 24.6B 22.94B
    Operating Income
    		 12.46B 10.92B 8.94B 8.36B 8.18B 7.53B 8.45B 8.21B 8.34B 9.09B 9.34B 9.86B 9.37B 8.23B 7.72B 6.22B 5.85B 5.23B
    Interest Income
    		 139M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Pretax Income
    		 6.59B 6.11B -8.38B -6.88B -6.42B -5.85B 8.44B 8.63B 8.7B 8.8B 7.71B 7.71B 7.66B 7.25B 8.1B -4.21B -4.11B -4.04B
    Net Income
    		 5.05B 5.42B -8.95B -7.26B -6.54B -6.15B 8.03B 8.29B 7.96B 7.31B 6.33B 6.68B 6.62B 6.25B 6.99B -5.41B -5.08B -6.22B
    Selling & General & Admin
    		 7.36B 7.59B 8.36B 8.32B 8.29B 8.29B 7.69B 7.89B 7.81B 7.67B 7.74B 7.82B 7.75B 7.85B 7.69B 8.05B 7.97B 7.71B
    Research & Development
    		 9.64B 9.67B 10.13B 9.82B 9.64B 9.61B 9.21B 9.25B 9.43B 9.49B 9.41B 9.51B 10.4B 11.35B 11.35B 11.54B 10.78B 9.99B
    Other Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Operating Expenses
    		 16.99B 17.26B 18.49B 18.14B 17.93B 17.9B 16.91B 17.14B 17.24B 17.16B 17.15B 17.33B 18.15B 19.2B 19.04B 19.59B 18.75B 17.7B
    Interest Expense
    		 1.98B 2.02B 1.95B 1.77B 1.54B 1.3B 1.17B 1.14B 1.16B 1.19B 1.23B 1.26B 1.29B 1.31B 1.33B 1.37B 1.38B 1.41B
    Selling & Marketing Expenses
    		 5.07B 5.07B 3.48B 1.98B n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 35.25B 36.71B 39.36B 39.08B 38.33B 38B 36.55B 36.72B 36.85B 36.76B 36.81B 36.87B 37.78B 38.73B 38.66B 39.25B 38.53B 37.58B
    Income Tax Expense
    		 1.53B 671M 554M 367M 109M 289M 400M 322M 720M 1.47B 1.37B 1.02B 1.02B 987M 1.08B 1.17B 948M 2.16B
    Shares Outstanding (Basic)
    		 2.04B 2.03B 2.03B 2.03B 2.03B 2.02B 2.03B 2.06B 2.09B 2.1B 2.11B 2.13B 2.13B 2.15B 2.15B 2.22B 2.23B 2.24B
    Shares Outstanding (Diluted)
    		 2.04B 2.04B 2.04B 2.03B 2.03B 2.02B 2.03B 2.06B 2.1B 2.11B 2.12B 2.15B 2.15B 2.16B 2.22B 2.24B 2.25B 2.27B
    EPS (Basic)
    		 2.49 2.68 -4.42 -3.59 -3.25 -3.09 3.88 3.97 3.78 3.46 2.98 3.12 3.07 2.87 3.17 -2.38 -2.25 -2.76
    EPS (Diluted)
    		 2.48 2.67 -4.42 -3.59 -3.26 -3.1 3.86 3.94 3.76 3.43 2.95 3.07 3.01 2.82 3.12 -2.4 -2.27 -2.78
    EBITDA
    		 15.09B 16.2B 3.17B 5.07B 5.15B 5.32B 19.37B 19.59B 19.83B 20.11B 19.22B 19.31B 19.42B 19.16B 20.12B 7.95B 8B 7.95B
    EBIT
    		 8.57B 8.12B -6.43B -5.11B -4.89B -4.56B 9.59B 9.75B 9.86B 9.99B 8.95B 8.97B 8.95B 8.56B 9.43B -2.85B -2.73B -2.63B
    Depreciation & Amortization
    		 6.51B 8.08B 9.6B 10.18B 10.03B 9.86B 9.76B 9.82B 9.97B 10.12B 10.28B 10.33B 10.47B 10.6B 10.69B 10.8B 10.72B 10.57B

    Add to Watchlist